IND-Enabling Assays

 HemoGenix^® has provided results using its proprietary assay platforms that have been included in IND applications to regulatory agenies. Indeed, our Study Plans, prepared individually for each study we perform, ask whether the results provided will be incorporated into an IND application and, if so, whether a special report format is required. This is part of our service to you.

Some competitors list assays that have remained unchanged since the 1960s as "cutting edge" IND-Enabling Services. At HemoGenix®, we prefer to use assays that not only incorporate the most sensitive signal detection system available, but are also standardized, validated and have the measurement assurance parameters to prove it.

For more information on our IND-Enabling Assay Service, please contact HemoGenix® at contractresearch@hemogenix.com or call (719) 264-6250.